Catalyst Wire Dossier Catalyst Wire Dossier

GP2017

adalimumab · Sandoz
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GP2017, covering 2017-04-07 to 2023-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) [Phase 3]

See pricing